Females | Males | Females and Males | |||||||
---|---|---|---|---|---|---|---|---|---|
15-59 | 60+ | All | 15-59 | 60+ | All | 15-59 | 60+ | All | |
Response rate, % | 70 | 76 | 72 | 58 | 77 | 64 | 64 | 77 | 68 |
Prevalence, responders | |||||||||
Responders, n | 1235 | 642 | 1877 | 993 | 532 | 1525 | 2228 | 1174 | 3402 |
Modified 1987 ACR, n | 3 | 7 | 10 | 0 | 5 | 5 | 3 | 12 | 15 |
Point prevalence, % | 0.24(0.05-0.71) | 1.09(0.44-2.23) | 0.53(0.26-0.98) | 0(0.00-0.37) | 0.94(0.31-2.18) | 0.33(0.11-0.76) | 0.14(0.03-0.39) | 1.02(0.53-1.78) | 0.44(0.25-0.73) |
Adjusted point prevalence, % | 0.46(0.17-0.74) | 0.24(0.03-0.44) | 0.35(0.17-0.52) | ||||||
Ever RA, n | 10 | 17 | 27 | 1 | 10 | 11 | 11 | 27 | 38 |
Cumulative prevalence, % | 0.81(0.39-1.48) | 2.65(1.55-4.21) | 1.44(0.95-2.10) | 0.10(0.00-0.56) | 1.88(0.91-3.43) | 0.72(0.36-1.29) | 0.49(0.25-0.88) | 2.30(1.52-3.33) | 1.12(0.79-1.53) |
Adjusted cumulative prevalence, % | 1.27(0.79-1.76) | 0.55(0.22-0.79) | 0.92(0.62-1.21) | ||||||
Prevalence, total sample | |||||||||
Total sample, n | 1757 | 840 | 2597 | 1709 | 689 | 2398 | 3466 | 1529 | 4995 |
Modified 1987 ACR, n | 3 | 7 | 10 | 0 | 5 | 5 | 3 | 12 | 15 |
Point prevalence, % | 0.17(0.04-0.50) | 0.83(0.34-1.71) | 0.39(0.19-0.71) | 0(0.00-0.22) | 0.73(0.24-1.69) | 0.21(0.07-0.49) | 0.09(0.02-0.25) | 0.79(0.41-1.37) | 0.30(0.17-0.50) |
Adjusted point prevalence, % | 0.34(0.13-0.55) | 0.18(0.02-0.34) | 0.26(0.13-0.39) | ||||||
Ever RA, n | 10 | 21 | 31 | 1 | 10 | 11 | 11 | 31 | 42 |
Cumulative prevalence, % | 0.57(0.27-1.05) | 2.50(1.55-3.80) | 1.19(0.81-1.69) | 0.06(0.00-0.33) | 1.45(0.70-2.65) | 0.46(0.23-0.82) | 0.32(0.16-0.57) | 2.03(1.38-2.87) | 0.84(0.61-1.14) |
Adjusted cumulative prevalence, % | 1.06(0.68-1.43) | 0.41(0.17-0.65) | 0.75(0.52-0.97) |